BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND PDGFRA, MGC74795, 5156, ENSG00000134853, PDGFR2, CD140A, Rhe-PDGFRA, CD140a, P16234 AND Treatment
11 results:

  • 1. Deciphering Genetic Alterations of Taiwanese Patients with pancreatic Adenocarcinoma through Targeted Sequencing.
    Huang CC; Liu CY; Huang CJ; Hsu YC; Lien HH; Wong JU; Tai FC; Ku WH; Hung CF; Lin JT; Huang CS; Chiang HS
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163506
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Kinome Array Profiling of Patient-Derived pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases.
    Creeden JF; Alganem K; Imami AS; Brunicardi FC; Liu SH; Shukla R; Tomar T; Naji F; McCullumsmith RE
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213062
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced pancreatic cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Rao AD; Liu Y; von Eyben R; Hsu CC; Hu C; Rosati LM; Parekh A; Ng K; Hacker-Prietz A; Zheng L; Pawlik TM; Laheru DA; Jaffee EM; Weiss MJ; Le DT; Hruban RH; De Jesus-Acosta A; Wolfgang CL; Narang AK; Chang DT; Koong AC; Herman JM
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):486-489. PubMed ID: 29157747
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Changes of diagnosis and treatment for gastrointestinal stromal tumors during a 18-year period in four medical centers of China].
    Qiu H; Zhang P; Feng X; Chen T; Sun X; Yu J; Chen Z; Li Y; Tao K; Li G; Zhou Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1265-1270. PubMed ID: 27928797
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer.
    Pettazzoni P; Viale A; Shah P; Carugo A; Ying H; Wang H; Genovese G; Seth S; Minelli R; Green T; Huang-Hobbs E; Corti D; Sanchez N; Nezi L; Marchesini M; Kapoor A; Yao W; Francesco ME; Petrocchi A; Deem AK; Scott K; Colla S; Mills GB; Fleming JB; Heffernan TP; Jones P; Toniatti C; DePinho RA; Draetta GF
    Cancer Res; 2015 Mar; 75(6):1091-101. PubMed ID: 25736685
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targets and candidate agents for type 2 diabetes treatment with computational bioinformatics approach.
    Wang Q; Zhao Z; Shang J; Xia W
    J Diabetes Res; 2014; 2014():763936. PubMed ID: 25401107
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A phase I, dose-finding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Grupo Español Multidisciplinario en Cáncer Digestivo (GEMCAD) study.
    Aparicio J; García-Mora C; Martín M; Petriz ML; Feliu J; Sánchez-Santos ME; Ayuso JR; Fuster D; Conill C; Maurel J
    PLoS One; 2014; 9(1):e82209. PubMed ID: 24416138
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Masitinib (AB1010), from canine tumor model to human clinical development: where we are?
    Marech I; Patruno R; Zizzo N; Gadaleta C; Introna M; Zito AF; Gadaleta CD; Ranieri G
    Crit Rev Oncol Hematol; 2014 Jul; 91(1):98-111. PubMed ID: 24405856
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. High KIT and pdgfra are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event.
    Knösel T; Chen Y; Altendorf-Hofmann A; Danielczok C; Freesmeyer M; Settmacher U; Wurst C; Schulz S; Yang LL; Petersen I
    J Cancer Res Clin Oncol; 2012 Mar; 138(3):397-403. PubMed ID: 22160160
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Kinome-wide siRNA screening identifies molecular targets mediating the sensitivity of pancreatic cancer cells to Aurora kinase inhibitors.
    Xie L; Kassner M; Munoz RM; Que QQ; Kiefer J; Zhao Y; Mousses S; Yin HH; Von Hoff DD; Han H
    Biochem Pharmacol; 2012 Feb; 83(4):452-61. PubMed ID: 22100984
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Positive immunohistochemical staining of KIT in solid-pseudopapillary neoplasms of the pancreas is not associated with KIT/pdgfra mutations.
    Cao D; Antonescu C; Wong G; Winter J; Maitra A; Adsay NV; Klimstra DS; Hruban RH
    Mod Pathol; 2006 Sep; 19(9):1157-63. PubMed ID: 16778826
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.